论文部分内容阅读
为进一步了解成年人基因乙肝疫苗(酵母重组基因乙肝疫苗)注射后抗体(抗-HBs)HB_s水平。以便对免疫效果做出评价,并为继续做好预防工作提供依据。我院于1996～1998年间对28名基因乙肝疫苗接种者进行了追踪调查,现将结果及分析报告如下。1 对象及方法1.1 对象 注射基因乙肝疫苗组为28人(其中女9人),平均年龄44.68岁(21～63岁);未注射乙肝疫苗组为173人(其中女41人),平均年龄38.17岁(20～62岁)。1.2 方法 经筛查注射组人员HBsAg、抗-HBs、和抗-HBc均
To further understand the HBs levels of antibodies (anti-HBs) after adult hepatitis B vaccine (yeast recombinant hepatitis B vaccine) injection. In order to make an assessment of the immune effect and provide a basis for continuing prevention work. Our hospital from 1996 to 1998 28 gene hepatitis B vaccination were followed up, the results and analysis are reported as follows. 1 Subjects and methods 1.1 Object Injection Hepatitis B vaccine group was 28 (9 were women), mean age 44.68 years (21 to 63 years); not injected hepatitis B vaccine group was 173 (41 women), the average age of 38.17 Years old (20 ~ 62 years old). 1.2 Methods The screening injection group of HBsAg, anti-HBs, and anti-HBc are